Skip to main content
Alteogen Inc. logo

Alteogen Inc. — Investor Relations & Filings

Ticker · 196170 ISIN · KR7196170005 KO Professional, scientific and technical activities
Filings indexed 293 across all filing types
Latest filing 2022-10-11 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 196170

About Alteogen Inc.

http://www.alteogen.com/

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Recent filings

Filing Released Lang Actions
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding the temporary suspension of stock trading for Alteogen due to a bonus issue (무상증자). It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding market activity that does not fit into specific categories like dividend declarations or share buybacks, it falls under the general regulatory filing category.
2022-10-11 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Alteogen, specifically detailing a 'Bonus Issue' (무상증자결정). A bonus issue is a corporate action involving the issuance of new shares to existing shareholders, which falls under capital changes. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the appropriate category for announcements regarding new share issues or capital changes.
2022-10-11 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling and details of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, location, purpose, and agenda for the meeting. Since this is an announcement of an event rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it falls under the category of a regulatory filing or announcement of corporate events.
2022-10-04 Korean
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a legal proceeding ('소송등의판결ㆍ결정' - Judgment/Decision on Litigation) involving a company, specifically detailing a court case (injunction for inspection of books) and its subsequent withdrawal. This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2022-09-26 Korean
소송등의제기ㆍ신청(경영권분쟁소송)(장부등열람허용가처분)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding (a lawsuit/injunction request) filed against the company Alteogen. It details the case name, the parties involved, the nature of the claim (inspection of books and records), and the company's planned legal response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant legal matters involving the company.
2022-09-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share transactions (stock option exercise and market sales) of an executive (Lee Seung-joo) of Alteogen. This falls under the category of Director's Dealing (insider trading/shareholding changes by executives).
2022-09-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.